Vascular Occlusion From Filler: Stages, Symptoms, Protocol 2026
Vascular occlusion is the most serious dermal filler complication. Stages, warning signs, the emergency hyaluronidase protocol, prevention — and what to do.
Quick Answer
Vascular occlusion is dermal filler material blocking a blood vessel — the most serious complication of filler injection. It is rare (≈1 in 100,000 injections for skin necrosis, 1 in 500,000 for vision loss) but every patient and every injector must know the warning signs and the emergency hyaluronidase protocol. The four stages run from blanching → livedo (lacy purple discoloration) → dusky/violaceous skin → necrosis. Treatment within 4-6 hours with high-dose hyaluronidase, warm compresses, topical nitroglycerin, aspirin, and pulsed massage usually prevents permanent damage. Highest-risk areas: glabella, nose, nasolabial folds, lips, infraorbital region.
What Is Vascular Occlusion?
Vascular occlusion (sometimes shortened to "VO" or "vasc occlusion") happens when filler material is inadvertently injected into or compresses a blood vessel, blocking blood flow to the tissue that vessel supplies. Two mechanisms:
- Intravascular injection — filler enters the lumen of an artery directly. The bolus is then carried along the vessel until it lodges, blocking flow downstream.
- Extravascular compression — filler placed adjacent to a vessel exerts enough pressure to collapse it from the outside.
Either way, downstream tissue is suddenly deprived of oxygen and nutrients. If circulation isn't restored, ischaemia progresses to necrosis (tissue death) within 6-12 hours. In rare cases, the bolus can travel retrograde into the ophthalmic artery and cause permanent vision loss.
The risk is low — published estimates put symptomatic VO at roughly 1 in 100,000 injections and vision-threatening events at 1 in 500,000 — but the consequences are serious enough that every injector must be prepared and every patient should know the early signs.
The 4 Stages of Vascular Occlusion
Recognising VO early is the single biggest determinant of whether the outcome is "we caught it and treated it" or "permanent scarring and necrosis". The progression:
Stage 1 — Immediate blanching and pain (0-30 minutes)
- Skin blanches white in the distribution of the affected vessel
- Pain is disproportionate to a normal injection — sharp, intense, often described as "burning" or "different from any pain I've felt with filler before"
- Capillary refill is slow when you press the area
- The pattern of blanching often follows the linear or branching distribution of the affected artery — not a uniform blob
This is the window where treatment is easiest and most reversible.
Stage 2 — Livedo reticularis (30 minutes to 24 hours)
- Lacy, net-like, blue-purple discoloration appears around the injection site
- The pattern reflects the network of cutaneous vessels that have lost flow
- Pain may temporarily decrease as the tissue becomes hypoxic — this is misleading and patients sometimes assume "it's getting better"
If recognised here, treatment still usually saves the tissue.
Stage 3 — Dusky / violaceous discoloration (1-3 days)
- Skin turns dark purple or grey-blue
- The area feels cool to the touch
- Blistering may begin as the upper epidermis begins to die
- Sensation may be reduced
At this stage permanent scarring is likely even with optimal treatment. Aggressive intervention can still salvage some viability.
Stage 4 — Necrosis (3-14 days)
- Black eschar (dead tissue) forms over the affected area
- The eschar eventually demarcates and separates, leaving a deep wound
- Healing is by secondary intention with scarring and pigmentation changes
By stage 4, the goal shifts from preventing damage to managing wound care and minimising the eventual scar.
Warning Signs Every Patient Should Know
If you've just had filler and notice any of these in the hours following the procedure, contact your injector immediately — this is a medical emergency:
- Severe pain that doesn't match what's normal for filler injection
- Skin that looks white, mottled, dusky purple, or "lacy" in the injected area
- Skin that feels cold compared to the other side
- Vision changes, eye pain, drooping eyelid, headache — these can indicate ophthalmic artery involvement and require immediate emergency care
- A blister or dark spot appearing in the day after injection
- Blanching that doesn't refill when you press the skin
Don't wait. Don't "see if it gets better overnight". Time is tissue.
Emergency Treatment Protocol
The standard published vascular occlusion protocol (consensus from ASDS, RealSelf, and recent dermatology literature):
Immediate (first hour)
- Stop injecting the moment VO is suspected
- Inject high-dose hyaluronidase — typically 200-500 units fanned into and around the affected area; can be repeated every 30-60 minutes for the first 4 hours if symptoms persist (HA fillers only — non-HA fillers like Sculptra and Radiesse cannot be enzymatically dissolved)
- Warm compresses to the area to promote vasodilation
- Topical nitroglycerin paste 2% — smear over the affected area to dilate the vessel
- Vigorous massage of the affected area to break up the bolus and stimulate flow
- Aspirin 325mg orally to prevent clot formation around the obstruction
- Photograph every 30 minutes for documentation
Hours 1-24
- Repeat hyaluronidase every 1-2 hours until colour returns and pain resolves
- Continue warm compresses, massage, nitroglycerin
- Consider sildenafil (Viagra) 25-50mg for additional vasodilation (off-label, increasingly used)
- Consider hyperbaric oxygen if available and signs persist
If vision changes occur
- Immediate transfer to ophthalmology / emergency department
- The window to save vision is approximately 60-90 minutes from onset
- Retrobulbar hyaluronidase by an experienced ophthalmologist is the only reported salvage (limited evidence)
Hyaluronidase dissolves hyaluronic acid filler within minutes when it reaches the obstructing material. For non-HA fillers (Sculptra, Radiesse, silicone, PMMA) the situation is much harder — these cannot be dissolved enzymatically and treatment relies on vasodilation, massage, and time.
Highest-Risk Anatomic Areas
Risk is not evenly distributed across the face. The areas with the densest end-arterial supply and the most documented VO events:
| Region | Vessel at risk | Why high-risk |
|---|---|---|
| Glabella (between brows) | Supratrochlear, supraorbital arteries | End-arterial; direct connection to ophthalmic system → vision-loss risk |
| Nose | Dorsal nasal, lateral nasal arteries | Tight anatomic compartment; difficult to aspirate |
| Nasolabial folds | Angular artery branches | Very common injection site; superficial arteries |
| Lips | Superior and inferior labial arteries | High-volume, high-flow region; common for cosmetic use |
| Infraorbital region | Infraorbital, angular arteries | Thin skin; visible PIH if VO occurs |
| Forehead | Supratrochlear, supraorbital | Same retrograde-to-ophthalmic risk as glabella |
The lower face (chin, jawline) has lower VO risk but is not immune.
Vascular occlusion from lip filler
Lip filler has a meaningful VO rate because the labial arteries run along predictable paths in the lip body. Most lip-filler VOs present as a sudden white patch on the lip or surrounding skin within minutes of injection, often with disproportionate pain. Treatment is the same protocol — high-dose hyaluronidase, warm compress, massage, nitroglycerin. Most lip VOs caught early resolve without scarring.
Vascular occlusion from skin boosters (Profhilo, Skinvive, Volite)
Skin boosters use lower-viscosity HA placed in superficial dermal blebs, which significantly reduces VO risk compared to volumising fillers — but it's not zero. Reported events are rare and usually involve injection technique that breached an underlying vessel. The same protocol applies. See our skin boosters review for the comparison.
Prevention Strategies
The strongest predictors of avoiding VO are anatomic knowledge and technique — not the brand of filler.
Injection Technique
- Use a blunt-tip cannula whenever possible — cannulas push vessels aside rather than piercing them, dramatically reducing intravascular injection risk in studies of cadaveric and clinical injection
- Inject slowly with low pressure — the goal is to feel the bolus move; rapid high-pressure injection is the most common technique error preceding VO
- Aspirate before injecting in high-risk areas — pull back on the plunger for 5-10 seconds; visible blood means stop and reposition
- Use the smallest volume necessary — large boluses are more likely to cross-section a vessel than small threaded injections
- Inject in the correct plane — most VOs occur when the needle/cannula is in the wrong tissue plane (subdermal vs supraperiosteal)
- Move the needle constantly — never inject into a stationary point; threading or fanning distributes the product safely
Product and Setup
- Choose hyaluronic acid fillers over permanent fillers — HA can be dissolved with hyaluronidase if VO occurs; non-HA cannot
- Have hyaluronidase immediately available — minimum 1,500 units on the tray, more if working in high-risk areas
- Have the emergency protocol on the wall — laminated cards in the procedure room are standard at experienced practices
- Know the local emergency referral path — which hospital, which ophthalmology department, which phone number
Anatomic Awareness
- Map the patient's vascular anatomy with doppler ultrasound in high-risk cases (especially nose and glabella)
- Avoid injecting in danger zones without specific advanced training
- Stop and reassess if anything feels wrong mid-procedure
What patients can do
- Choose a board-certified dermatologist or plastic surgeon — VO outcomes are dramatically better in experienced hands
- Confirm before booking that the injector keeps hyaluronidase on hand
- Ask the injector to describe their VO emergency protocol — if they fumble the answer, leave
- Avoid medspa Botox parties, mobile injectors, and unlicensed providers
Frequently Asked Questions
What is vascular occlusion in filler?
Vascular occlusion is when dermal filler material blocks a blood vessel, either by being injected directly into the vessel or by compressing it from outside. The blocked vessel can no longer supply oxygen to the downstream tissue, and without rapid treatment the tissue dies (necrosis). It is the most serious complication of filler injection.
What are the stages of vascular occlusion?
The four stages are: (1) immediate blanching and disproportionate pain within minutes; (2) livedo reticularis — a lacy, blue-purple net-like discoloration over 30 minutes to 24 hours; (3) dusky violaceous skin and possible blistering at 1-3 days; (4) frank necrosis with black eschar at 3-14 days. Recognising it at stage 1 or 2 is the difference between a salvageable injury and permanent scarring.
What are the symptoms of vascular occlusion?
The classic symptoms are severe pain disproportionate to a normal injection, immediate blanching (whitening) of the skin in a vascular distribution, slow capillary refill, lacy blue-purple discoloration developing within hours, cold skin, and eventual blistering or dark patches. Vision changes, eye pain, drooping eyelid, or sudden headache after facial filler are signs of ophthalmic artery involvement and require immediate emergency care.
What is the vascular occlusion protocol?
The standard protocol: stop the injection immediately, inject high-dose hyaluronidase (200-500 units) into and around the affected area and repeat every 30-60 minutes for the first 4 hours, apply warm compresses, apply topical nitroglycerin paste, take aspirin 325mg, vigorously massage the area to break up the bolus, and arrange close monitoring. For non-HA fillers, hyaluronidase doesn't work and treatment relies on vasodilation, massage, and time. Vision changes require immediate ophthalmology transfer.
What are the signs of vascular occlusion after filler?
Signs to watch for in the hours after filler injection: severe or worsening pain that doesn't match normal injection discomfort, skin that looks white or mottled in the treated area, lacy blue-purple discoloration spreading from the injection site, skin that feels cold compared to the opposite side, a blister or dark spot appearing the day after, vision changes, eye pain, or sudden headache. Any of these warrant immediate contact with the injector.
Can vascular occlusion be reversed?
Yes — if recognised early. Treatment with high-dose hyaluronidase within the first 4-6 hours dissolves HA filler and usually restores blood flow before tissue death occurs. The earlier treatment starts, the better the outcome. Treatment delayed beyond 12 hours is unlikely to prevent some degree of scarring or pigment change.
How common is vascular occlusion from filler?
Estimates from registry data and large practice surveys suggest about 1 in 100,000 injections result in clinically significant vascular occlusion with skin compromise, and roughly 1 in 500,000 result in vision-threatening events. Risk varies by anatomic region (highest in glabella and nose), filler product, and injector experience.
Can vascular occlusion happen with lip filler?
Yes. Lip filler has a documented VO rate because the superior and inferior labial arteries run along predictable paths in the lip body. Most lip-filler VOs present as a sudden white patch on the lip or surrounding skin within minutes of injection, often with sharp, disproportionate pain. Treated promptly, most resolve without scarring.
Can skin boosters cause vascular occlusion?
Yes, but very rarely. Skin boosters (Profhilo, Skinvive, Volite) use low-viscosity HA placed in superficial dermal blebs, which significantly reduces VO risk compared to volumising fillers. The few reported events involve injection technique that breached a vessel. The same emergency protocol applies.
What does livedo reticularis look like in vascular occlusion?
Livedo reticularis from vascular occlusion is a lacy, net-like, blue-purple pattern that appears on the skin downstream of the blocked vessel. It typically develops within 30 minutes to 24 hours after the occlusion. The pattern reflects the cutaneous vascular network that has lost its arterial supply — the net of capillaries shows up because they're filled with deoxygenated blood and no fresh oxygenated blood is replacing it.
How fast does vascular occlusion progress?
Untreated, vascular occlusion progresses from blanching → livedo → dusky discoloration → necrosis over 6-12 hours. Some events (especially in the nose) progress faster — visible necrosis can begin within 4 hours. With prompt high-dose hyaluronidase treatment, the progression is usually halted at stage 1 or 2.
Can vascular occlusion cause blindness?
Yes — extremely rarely. If filler injected near the glabella, forehead, or nose enters a small artery that connects retrograde to the ophthalmic artery, the bolus can travel into the ocular vasculature and cause sudden vision loss. The published rate is roughly 1 in 500,000 injections, and most cases are permanent because the salvage window (60-90 minutes) is shorter than most patients reach an ophthalmologist.
How do I choose a safe filler injector?
Choose a board-certified dermatologist or plastic surgeon, or a nurse practitioner / PA working under direct physician supervision. Confirm before booking that they keep hyaluronidase on hand. Ask them to describe their emergency vascular occlusion protocol — if they fumble or downplay it, leave. Prefer injectors who use cannula technique in high-risk areas, perform high monthly volume of filler, and use HA fillers (which can be dissolved) over non-HA fillers (which cannot).
What's the difference between vascular occlusion and a normal bruise?
A bruise is dark blue-black or yellow-green, soft, painless after the first day, and limited to the immediate injection site — it appears slowly over hours to days. Vascular occlusion presents with sharp pain in real time during or right after injection, blanching (white) rather than dark colour at first, a net-like livedo pattern that follows vascular anatomy rather than a blob, and often cold-feeling skin. If you can't tell which it is, photograph and contact your injector immediately — VO is too serious to wait out.
The Bottom Line
Vascular occlusion is rare but serious. The keys to good outcomes are: choose an experienced injector who keeps hyaluronidase on the tray; know the warning signs (severe pain, blanching, lacy discoloration, cold skin) and act on them within the first few hours rather than waiting; insist on HA fillers over permanent fillers in high-risk areas; and never accept "let's see if it gets better tomorrow" as an answer when something looks wrong after filler. Most vascular occlusions caught at stage 1 resolve completely; most caught at stage 4 leave permanent scars.
